National Viral Hepatitis Control Program
Dr Sandhya Kabra
Deputy Commissioner, NVHCP
National Viral Hepatitis Control Program
SDG goal 3.3 to ….combat viral hepatitis
Aims
• Elimination of Hepatitis C by 2030
• Reduction in the infected population, morbidity and mortality
associated with Hepatitis B and C
• Reduce the risk, morbidity and mortality due to Hepatitis A and E.
Key Objectives
• Enhance community awareness on hepatitis and lay stress on
preventive measures
• Provide early diagnosis and management of viral hepatitis at all
levels of healthcare
• Develop capacities for implementation of standard diagnostic
and treatment protocols
Key Objectives
• Strengthen the existing infrastructure facilities
• build capacities of existing human resource
• raise additional human resources, only where required
• Develop linkages with the existing programs/ ministerial
activities
• NACP, Immunisation, MH, Mo Drinking water and Sanitation
Five key documents
Overall Framework- Snapshot
- Guideline and Policy
Formulation
- M & E, Surveillance, Research
- Central Procurement
NPMU - Coordination
Annual PIP and targets, State
SPMU level planning & scaleup,
intersectoral coordination,
M&E
Labs and
Treatment sites
Diagnosis, Treatment,
Referral, Quality Control
Key interventions-Prevention
• Awareness generation & Behavior Change Communication
• Immunization for hepatitis B – birth dose, high risk groups, health
care workers
• Provision of safe blood and blood products
• Injection Safety by Use of RUP/AD syringes in all government HCFs
• Safe socio-cultural practices
Key interventions-Diagnosis & Treatment
•Screening - serological tests
•Confirmation - molecular tests (where required)
•Treatment of uncomplicated cases - at treatment centres, drug
dispensation up to HWC
•Treatment of complicated cases at model treatment centres
•Referral and linkages
•Capacity building and quality assurance
Model for Diagnosis
Model for Treatment
Model Treatment centers for
Medical Treatment of Hepatitis B & C for
colleges and complicated cases & management of
Tertiary centers other hepatitis;
Phased
scale District Hospitals / Treatment centers for Treatment of
up Secondary care Hepatitis B & C; Refer complicated
cases to Model Treatment Centers
Sub District level Dispensation
Intersectoral collaboration
Swachh
Bharat MCH
•NVHCP Immunization
•( All 5 viruses) NACP
•Awareness generation
•Prevention
•Diagnosis
•Management HCW
Injection
Safety
Surveillance
Current Status
• 710 centers functional in all States/Uts
• 75 lakh patients screened for Hepatitis B and C and 71, 000app.
patients started treatment (Sept 2018 to March 2021)
• Consolidated the smaller projects and state programs under the
National program for harmonization
• Introduction of hepatitis B testing for pregnant women
• Guidance on vaccination for health care workers at risk
• Guidance to shift towards RUP in government sector in a phased
manner
• Targeted testing started: vulnerable population groups prioritized
Status Update – NVHCP States wise
At least one Intersectoral
functional Treatment Procurement Coordination
S. No. State Sites per district RDTs HBIG RCH NACP
1 Andhra Pradesh Yes Yes Yes Yes Yes
2 Arunachal Pradesh Partial Partial No No No
3 Bihar No No Partial No No
4 Himachal Pradesh Partial Yes No Partial No
5 Jharkhand Partial Partial Partial No No
6 Mizoram Yes Yes Yes Partial Partial
7 Rajasthan Yes Yes Yes Yes Yes
8 Tripura Yes Yes Partial Partial Partial
9 Uttar Pradesh Partial Yes Partial Partial Partial
10 West Bengal Yes Yes Yes Yes Yes
Request to States
• Establishment of State Viral Hepatitis Control Management Unit (SVHMU)
and State Steering Committee with at-least one positive community
representative as member.
• Establishment of at least one Model Treatment Centre (MTC) & State
Referral Lab in every state and treatment sites & diagnostic facilities in all
districts.
• Master trainers trained in all states/UTs. States to cascade trainings for
diagnosis and management of viral hepatitis along with portal entry on MIS
in all aspects till facility level.
• Screening of all pregnant women for Hepatitis B Surface Antigen (HBsAg)&
referral of all those who screen positive for institutional delivery to ensure
that the newborn receives birth dose of hepatitis B along with Hepatitis B
Immunoglobulin (HBIG) to prevent mother to child transmission.
National helpline for viral hepatitis (1800-11-6666); website: [Link]
Thank You
